Literature DB >> 23380586

Systemic immune system alterations in early stages of Alzheimer's disease.

Rongzhen Zhang1, Robert G Miller, Catherine Madison, Xia Jin, Ronald Honrada, Will Harris, Jonathan Katz, Dallas A Forshew, Michael S McGrath.   

Abstract

Immune activation and inflammation play significant roles in the pathogenesis of Alzheimer's disease (AD). To test whether AD patients showed systemic manifestations of inflammation, blood from 41 patients with early stages of AD and 31 aged-match elderly controls were evaluated. Cellular markers for monocyte/macrophage (MO) activation and CD8 T lymphocyte were increased in early AD patients. Expression of monocyte CCR2, the receptor for monocyte chemoattractant protein-1 (MCP-1), was decreased; however, plasma MCP-1 levels were significantly increased and were related to the degree of MO activation in AD. These findings suggest that AD pathogenesis may be influenced by systemic immunologic dysfunction and provides potential immunologic targets for therapeutic intervention. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380586      PMCID: PMC3641776          DOI: 10.1016/j.jneuroim.2013.01.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  66 in total

Review 1.  Modern care for patients with Alzheimer disease: rationale for early intervention.

Authors:  Katherine E Galluzzi; Denah M Appelt; Brian J Balin
Journal:  J Am Osteopath Assoc       Date:  2010-09

2.  Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Daniel C Parker; Michelle M Mielke; Qilu Yu; Paul B Rosenberg; Alka Jain; Constantine G Lyketsos; Neal S Fedarko; Esther S Oh
Journal:  Int J Geriatr Psychiatry       Date:  2012-04-27       Impact factor: 3.485

3.  Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases.

Authors:  Takashi Togo; Haruhiko Akiyama; Eizo Iseki; Hiromi Kondo; Kenji Ikeda; Masanori Kato; Tatsuro Oda; Kuniaki Tsuchiya; Kenji Kosaka
Journal:  J Neuroimmunol       Date:  2002-03       Impact factor: 3.478

Review 4.  Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning.

Authors:  F Mennicken; R Maki; E B de Souza; R Quirion
Journal:  Trends Pharmacol Sci       Date:  1999-02       Impact factor: 14.819

5.  Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice.

Authors:  Deren Huang; Jerome Wujek; Graham Kidd; Toby T He; Astrid Cardona; Margaret E Sasse; Erica J Stein; Jacqueline Kish; Marie Tani; Israel F Charo; Amanda E Proudfoot; Barrett J Rollins; Tracy Handel; Richard M Ransohoff
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

6.  Unique monocyte subset in patients with AIDS dementia.

Authors:  L Pulliam; R Gascon; M Stubblebine; D McGuire; M S McGrath
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

7.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

8.  Acute-phase proteins in Alzheimer's disease.

Authors:  B Giometto; V Argentiero; F Sanson; G Ongaro; B Tavolato
Journal:  Eur Neurol       Date:  1988       Impact factor: 1.710

9.  Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

Authors:  L Izikson; R S Klein; I F Charo; H L Weiner; A D Luster
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.

Authors:  D R Huang; J Wang; P Kivisakk; B J Rollins; R M Ransohoff
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  44 in total

1.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 2.  Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 3.  Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.

Authors:  Chang Liu; Guohong Cui; Meiping Zhu; Xiangping Kang; Haidong Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Hong-Ri Zhang; Jing-Hua Peng; Xiao-Bing Cheng; Bao-Zhong Shi; Mao-Ying Zhang; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2015-06-12       Impact factor: 3.996

5.  Perioperative frailty.

Authors:  Levana G Amrock; Stacie Deiner
Journal:  Int Anesthesiol Clin       Date:  2014

6.  Women's Pregnancy Life History and Alzheimer's Risk: Can Immunoregulation Explain the Link?

Authors:  Molly Fox; Carlo Berzuini; Leslie A Knapp; Laura M Glynn
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-07-30       Impact factor: 2.035

Review 7.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

Authors:  Subbiah Pugazhenthi; Limei Qin; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-05-06       Impact factor: 5.187

8.  SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1-42 into hippocampus of mice.

Authors:  Jiejie Guo; Lan Chang; Chenli Li; Mengmeng Li; Peiyun Yan; Zhiping Guo; Chuang Wang; Qin Zha; Qinwen Wang
Journal:  Metab Brain Dis       Date:  2016-08-03       Impact factor: 3.584

9.  Identification of oxidative modifications of hemopexin and their predicted physiological relevance.

Authors:  Peter Hahl; Rachel Hunt; Edward S Bjes; Andrew Skaff; Andrew Keightley; Ann Smith
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

Review 10.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.